Tonira Pharma

Jump to

Ipca Labs hopes to achieve 18-20% growth for FY12

AK Jain, the executive director of Ipca Labs, in an interview on CNBC-TV18, talks about the latest happenings in the company and sector.
Tonira Pharma to merge with Ipca Labs; stock up 6%

Tonira Pharma will merge with Ipca Laboratories. IPCA currently holds more than 32% on Tonira, reports Business Standard. It touched an intraday high of Rs 25 and an intraday low of Rs 23.50. At 09:30 hrs the share was quoting at Rs 23.85, up Rs 1.35, or 6%.
Tonira Pharma Mar '11 sales at Rs 5.09 crore

Tonira Pharma has reported a sales turnover of Rs 5.09 crore and a net loss of Rs 1.05 crore for the quarter ended Mar '11
Tonira Pharma Dec '10 sales at Rs 10.05 crore

Tonira Pharma has reported a sales turnover of Rs 10.05 crore and a net profit of Rs 0.40 crore for the quarter ended Dec '10

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Tonira Pharma

Ipca Labs hopes to achieve 18-20% growth for FY12

Tonira Pharma to merge with Ipca Labs; stock up 6%

Tonira Pharma Mar '11 sales at Rs 5.09 crore

Tonira Pharma Dec '10 sales at Rs 10.05 crore